Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02289157 · ClinicalTrials.gov registry record · NA
Negative Pressure Wound Therapy in Cesarean Section
A NA study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 441
- Enrollment target
NCT02289157: Completed NA study, sponsored by University of Texas Southwestern Medical Center.
NCT02289157 is a NA study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 441 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02289157, a NA study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 441 participants
- Enrollment target
Study Summary
The investigators propose a prospective, randomized trial evaluating the use of negative pressure wound therapy (NPWT) with high risk obstetrical patients. The investigators hypothesize that negative pressure wound therapy will decrease the wound complications in these patients. The investigators aim to look at all wound complications such as infection and disruption and will be using Prevena incision management system for our NPWT device .
Primary Outcome
Number of Patients with Wound infection complications: hematoma, seroma, dehiscence, or Surgical Site Infection.
Interventions
- DEVICE Negative pressure wound therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 441 participants |
| Start Date | 2015-01-27 |
| Est. Completion | 2016-10-21 |
| Phase | NA |
What the finished NCT02289157 record still lists
NCT02289157 is an interventional study that assigns participants to a tested intervention. The registered 441 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower).
The record links to 0 conditions, and to 1 intervention - of which Negative pressure wound therapy is the first listed.
NCT02289157 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02289157 about?
NCT02289157 is a clinical study titled "Negative Pressure Wound Therapy in Cesarean Section". The investigators propose a prospective, randomized trial evaluating the use of negative pressure wound therapy (NPWT) with high risk obstetrical patients. The investigators hypothesize that negative pressure wound therapy will decrease the wound complications in these patients. The investigators ai...
What is the current status of trial NCT02289157?
This trial is currently completed. It is a NA study. The enrollment target is 441 participants. The study started on 2015-01-27. Estimated completion is 2016-10-21.
What interventions are being tested in trial NCT02289157?
The interventions under investigation include: Negative pressure wound therapy (DEVICE).
Who is sponsoring clinical trial NCT02289157?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02289157's enrollment target sits among peer trials
441 233rd of 2000 higher than 1,768 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02679144 · 441 participants · Phase 2
Neuroblastoma Maintenance Therapy Trial
- NCT03704766 · 442 participants · NA
Alpha-Defensin and Synovial Proteins to Improve Detection of Pediatric Septic Arthritis
- NCT04657068 · 442 participants · Phase 1
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- NCT05410145 · 442 participants · Phase 1
A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI